The company intends to increase its specialty drug portfolio in its core areas ... The company’s Halol plant, receiving an import alert from the USFDA earlier in December, remains a challenge for Sun.
Drug major Sun Pharmaceutical on Friday announced that it is set to acquire 60 per cent shareholding in Vivaldis Health & Foods for ₹143.30 crore from its existing shareholders, The remaining 40 ...
DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq ... Through its PLAIR, Avadel is authorized to import unapproved drug product into the U.S. ahead of ...
Recently, Sun Pharma has also acquired Concert, a US-based pharmaceuticals firm, in January. The Mumbai-based company inked a pact to acquire Concert in a USD 576 million deal. On Friday, the ...
The U.S. Food and Drug ... Pharmaceuticals' (NASDAQ:AVDL) pre-launch activities importation requests (PLAIR) for sleep disorder therapy Lumryz. Through the PLAIR, Avadel is authorized to import ...
Sun Pharma currently believes that the incident’s effect on its IT systems includes a breach of certain file systems and the ...
(RTTNews) - Biopharmaceutical company Avadel Pharmaceuticals plc (AVDL ... Through its PLAIR, Avadel is authorized to import unapproved drug product into the U.S. ahead of anticipated final ...
The NSE Nifty dropped 75 points, or 0.44 per cent, to settle at 17,076.90. Select stocks such as Sun Pharmaceuticals, Vedanta and Infosys were on traders' radar. Here is what Rohan Shah ...
DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals ... Drug Administration (“FDA”) has approved its Pre-Launch Activities Importation Requests (PLAIR) for ...
Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceuticals company, has received final approval by the United States Food & Drug Administration (FDA) for calcipotriene and ...
